Lung Cancer aims to provide individuals or organisations with the most recent information on lung cancer and other thoracic malignancies.
The Journal publishes original research and review articles on clinical and basic science aspects of topics represented by the fields
of interest of Lung Cancer (prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy,
radiotherapy, combined treatment modalities, other treatment modalities, outcomes). Manuscripts describing studies on cell lines will
only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding
of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of
the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial
suppliers.
